ARTICLE | Company News
Receptagen supply/service, cancer news
October 30, 1995 8:00 AM UTC
The Vancouver company sued the former shareholders of Ryan Pharmaceuticals Inc. in an effort to clarify the interpretation of a clause in the share exchange agreement entered when RCEPF acquired Ryan in 1993.
As part of that agreement, RCEPF granted Ryan shareholders a 5 percent royalty on net sales of CoQ10, a naturally occurring enzyme involved in energy metabolism. ...